Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wexler

Showing results (311-320 of 418) with videos related to

Pageof 42
Sort By:
Journal of Medicinal Chemistry|January 3, 1997
Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonistsJ Wityak, T M Sielecki, D J Pinto, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2014
Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moietiesMichael J Orwat, Jennifer X Qiao, Kan He, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2021
Identification of 6-hydroxy-5-phenyl sulfonylpyrimidin-4(1H)-one APJ receptor agonistsGeorge Tora, Ji Jiang, Jeffrey S Bostwick, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 5, 2011
Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitorKan He, Joseph M Luettgen, Donglu Zhang, et al.
Coronary Artery Disease|October 1, 1996
Novel nonpeptide antiplatelet glycoprotein IIb/IIIa receptor antagonist, DMP754: receptor binding affinity and specificityS A Mousa, M Forsythe, W Lorelli, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor XaYun-Long Li, John M Fevig, Joseph Cacciola, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Nonbenzamidine isoxazoline derivatives as factor Xa inhibitorsMimi L Quan, Christopher D Ellis, Ming Y He, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identificationChu-Biao Xue, Xiaohua He, John Roderick, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a Potent I Kur InhibitorHeather J Finlay, James A Johnson, John L Lloyd, et al.
Journal of Medicinal Chemistry|July 30, 1999
Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 1M L Quan, A Y Liauw, C D Ellis, et al.
Pageof 42

Showing results (311-320 of 418) with videos related to

Sort By:
Pageof 42
Journal of Medicinal Chemistry|January 3, 1997
Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonistsJ Wityak, T M Sielecki, D J Pinto, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2014
Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moietiesMichael J Orwat, Jennifer X Qiao, Kan He, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2021
Identification of 6-hydroxy-5-phenyl sulfonylpyrimidin-4(1H)-one APJ receptor agonistsGeorge Tora, Ji Jiang, Jeffrey S Bostwick, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 5, 2011
Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitorKan He, Joseph M Luettgen, Donglu Zhang, et al.
Coronary Artery Disease|October 1, 1996
Novel nonpeptide antiplatelet glycoprotein IIb/IIIa receptor antagonist, DMP754: receptor binding affinity and specificityS A Mousa, M Forsythe, W Lorelli, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor XaYun-Long Li, John M Fevig, Joseph Cacciola, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Nonbenzamidine isoxazoline derivatives as factor Xa inhibitorsMimi L Quan, Christopher D Ellis, Ming Y He, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identificationChu-Biao Xue, Xiaohua He, John Roderick, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a Potent I Kur InhibitorHeather J Finlay, James A Johnson, John L Lloyd, et al.
Journal of Medicinal Chemistry|July 30, 1999
Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 1M L Quan, A Y Liauw, C D Ellis, et al.
Pageof 42